"Since my spinal cord injury, I have constant nerve pain which feels like someone is pouring hot coals over my body. I'm excited that through this new brain technology treatment, I can learn how ...

Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.

It could be, if it’s FDA-approved, the first of a new class of pain medications. And so what it’s doing is it’s targeting these sodium channels that are scattered along our nerve cells in ...

The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...

On October 11, the recall was classified as a class II recall by the FDA—a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health ...

Zen types will tell you to accept the itch, to meditate on it, as you might do if you were in pain. These people have no idea ...

In people with this disease, small fibres of TTR protein clump together to make deposits called 'amyloid'. Amyloid can build ...

The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high ...

Starting MS treatment ... to the nerve cells that cause your disease to worsen. Early treatment with DMTs specifically and other therapies for symptom management may also reduce pain and help ...

("NeurAxis,” or the "Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...